rs1529663

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001244008.2(KIF1A):​c.4319-8C>T variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00981 in 1,529,832 control chromosomes in the GnomAD database, including 776 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.043 ( 399 hom., cov: 33)
Exomes 𝑓: 0.0062 ( 377 hom. )

Consequence

KIF1A
NM_001244008.2 splice_region, intron

Scores

2
Splicing: ADA: 0.0002721
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 0.00700

Publications

4 publications found
Variant links:
Genes affected
KIF1A (HGNC:888): (kinesin family member 1A) The protein encoded by this gene is a member of the kinesin family and functions as an anterograde motor protein that transports membranous organelles along axonal microtubules. Mutations at this locus have been associated with spastic paraplegia-30 and hereditary sensory neuropathy IIC. Alternatively spliced transcript variants encoding distinct isoforms have been described. [provided by RefSeq, Apr 2012]
KIF1A Gene-Disease associations (from GenCC):
  • intellectual disability, autosomal dominant 9
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
  • syndromic intellectual disability
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • neuropathy, hereditary sensory, type 2C
    Inheritance: AR Classification: DEFINITIVE, STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
  • hereditary spastic paraplegia 30
    Inheritance: AR, AD Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet
  • autosomal dominant non-syndromic intellectual disability
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • PEHO syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hereditary sensory and autonomic neuropathy type 2
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 2-240723566-G-A is Benign according to our data. Variant chr2-240723566-G-A is described in ClinVar as Benign. ClinVar VariationId is 129394.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.14 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KIF1ANM_001244008.2 linkc.4319-8C>T splice_region_variant, intron_variant Intron 41 of 48 ENST00000498729.9 NP_001230937.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KIF1AENST00000498729.9 linkc.4319-8C>T splice_region_variant, intron_variant Intron 41 of 48 5 NM_001244008.2 ENSP00000438388.1

Frequencies

GnomAD3 genomes
AF:
0.0427
AC:
6490
AN:
152132
Hom.:
400
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.143
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0169
Gnomad ASJ
AF:
0.0214
Gnomad EAS
AF:
0.000578
Gnomad SAS
AF:
0.00870
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0158
Gnomad NFE
AF:
0.00141
Gnomad OTH
AF:
0.0339
GnomAD2 exomes
AF:
0.0127
AC:
1986
AN:
155794
AF XY:
0.0109
show subpopulations
Gnomad AFR exome
AF:
0.148
Gnomad AMR exome
AF:
0.00789
Gnomad ASJ exome
AF:
0.0250
Gnomad EAS exome
AF:
0.000783
Gnomad FIN exome
AF:
0.0000639
Gnomad NFE exome
AF:
0.00204
Gnomad OTH exome
AF:
0.00972
GnomAD4 exome
AF:
0.00618
AC:
8510
AN:
1377582
Hom.:
377
Cov.:
32
AF XY:
0.00579
AC XY:
3907
AN XY:
674736
show subpopulations
African (AFR)
AF:
0.150
AC:
4693
AN:
31332
American (AMR)
AF:
0.00972
AC:
347
AN:
35686
Ashkenazi Jewish (ASJ)
AF:
0.0271
AC:
668
AN:
24686
East Asian (EAS)
AF:
0.00138
AC:
49
AN:
35626
South Asian (SAS)
AF:
0.00815
AC:
636
AN:
78016
European-Finnish (FIN)
AF:
0.0000835
AC:
4
AN:
47898
Middle Eastern (MID)
AF:
0.0168
AC:
68
AN:
4038
European-Non Finnish (NFE)
AF:
0.00120
AC:
1281
AN:
1063488
Other (OTH)
AF:
0.0134
AC:
764
AN:
56812
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
385
770
1156
1541
1926
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
186
372
558
744
930
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0427
AC:
6500
AN:
152250
Hom.:
399
Cov.:
33
AF XY:
0.0407
AC XY:
3028
AN XY:
74434
show subpopulations
African (AFR)
AF:
0.143
AC:
5952
AN:
41526
American (AMR)
AF:
0.0169
AC:
258
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.0214
AC:
74
AN:
3466
East Asian (EAS)
AF:
0.000579
AC:
3
AN:
5178
South Asian (SAS)
AF:
0.00850
AC:
41
AN:
4822
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10630
Middle Eastern (MID)
AF:
0.0170
AC:
5
AN:
294
European-Non Finnish (NFE)
AF:
0.00141
AC:
96
AN:
68006
Other (OTH)
AF:
0.0336
AC:
71
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
282
565
847
1130
1412
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
58
116
174
232
290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0220
Hom.:
87
Bravo
AF:
0.0485
Asia WGS
AF:
0.00837
AC:
30
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
-
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -

May 26, 2015
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 31, 2024
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Hereditary spastic paraplegia Benign:1
Jan 14, 2022
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hereditary spastic paraplegia 30 Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Neuropathy, hereditary sensory, type 2C;C5235139:Hereditary spastic paraplegia 30;C5393830:Intellectual disability, autosomal dominant 9 Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
4.7
DANN
Benign
0.85
PhyloP100
0.0070
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.00027
dbscSNV1_RF
Benign
0.018
SpliceAI score (max)
0.070
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1529663; hg19: chr2-241662983; API